PUBLICATION EXCLUSIVE: From the outside looking in at anti-VEGF therapy

As an anterior segment surgeon, I am a little out of my comfort zone commenting on the details of the many studies evaluating the indications and outcomes after the use of anti-VEGF therapy. I do not perform intravitreal injections of anti-VEGF, nor do any of the 26 doctors at Minnesota Eye Consultants. We do, however, have many patients in our practice who are being treated by retina specialist colleagues.My first impression is that intravitreal anti-VEGF therapy for wet age-related macular degeneration, diabetic retinopathy and macular edema from a host of (Read more...)

Full Story →